Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 35, 2024 - Issue 1
Submit an article Journal homepage
812
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy

Jarmila Čelakovskáa Department of Dermatology and Venereology, Faculty Hospital and Medical Faculty of Charles University, Hradec Králové, Czech RepublicCorrespondence[email protected]
View further author information
,
Eva Čermákováb Department of Medical Biophysics, Medical Faculty of Charles University, Hradec Králové, Czech RepublicView further author information
,
Petra Boudkovac Department of Clinical Immunology and Allergy, Faculty Hospital and Medical Faculty of Charles University, Hradec Králové, Czech RepublicView further author information
&
Jan Krejsekc Department of Clinical Immunology and Allergy, Faculty Hospital and Medical Faculty of Charles University, Hradec Králové, Czech RepublicView further author information
Article: 2299721 | Received 20 Dec 2023, Accepted 21 Dec 2023, Published online: 04 Jan 2024

References

  • Mjösberg J, Eidsmo L. Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin. Clin Exp Allergy. 2014;44(8):1–4. PMID: 24912880. doi: 10.1111/cea.12353.
  • Zheng M, Zhu J. Innate lymphoid cells and intestinal inflammatory disorders. Int J Mol Sci. 2022; 23(3):1856. doi: 10.3390/ijms23031856.
  • D’Ippolito D, Pisano M. Dupilumab (dupixent): an interleukin-4 receptor antagonist for atopic dermatitis. P T. 2018;43(9):532–535.
  • Furue M, Ulzii D, Nakahara T, et al. Implications of IL-13Rα2 in atopic skin inflammation. Allergol Int. 2020;69(3):412–416. doi: 10.1016/j.alit.2020.01.005.
  • Kirchberger S, Royston DJ, Boulard O, et al. Innate lymphoid cells sustain Colon cancer through production of interleukin-22 in a mouse model. J Exp Med. 2013;210(5):917–931. doi: 10.1084/jem.20122308.
  • Alkon N, Bauer WM, Krausgruber T, et al. Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis. J Allergy Clin Immunol. 2022;149(2):624–639. Feb doi: 10.1016/j.jaci.2021.07.025.
  • Eisenring M, Vom Berg J, Kristiansen G, et al. IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46. Nat Immunol. 2010;11(11):1030–1038. doi: 10.1038/ni.1947.
  • Nussbaum K, Burkhard SH, Ohs I, et al. Tissue microenvironment dictates the fate and tumor-suppressive function of type 3 ILCs. J Exp Med. 2017;214(8):2331–2347. doi: 10.1084/jem.20162031.
  • Carrega P, Loiacono F, Di Carlo E, et al. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun. 2015;6(1):8280. doi: 10.1038/ncomms9280.
  • Chang Y, Kim JW, Yang S, et al. Increased GM-CSF-producing NCR- ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease. Clin Transl Immunology. 2021;10(7):e1311. Jul 8
  • Liu Y, Song Y, Lin D, et al. NCR- group 3 innate lymphoid cells orchestrate IL-23/IL-17 axis to promote hepatocellular carcinoma development. EBioMedicine. 2019;41:333–344. Mar doi: 10.1016/j.ebiom.2019.02.050.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.